Holen Sie sich die Stockscreener-App
11.23
1.23%
-0.1837
Schlusskurs vom Vortag:
$11.41
Offen:
$11.26
24-Stunden-Volumen:
116.16K
Relative Volume:
0.49
Marktkapitalisierung:
$111.81M
Einnahmen:
$6.39M
Nettoeinkommen (Verlust:
$-117.26M
KGV:
-0.8995
EPS:
-12.4807
Netto-Cashflow:
$-79.08M
1W Leistung:
-2.00%
1M Leistung:
-3.68%
6M Leistung:
-68.74%
1J Leistung:
-52.49%
1-Tages-Spanne:
$10.91
$11.40
1-Wochen-Bereich:
$10.91
$14.79
52-Wochen-Spanne:
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Compare KRRO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
11.27 | 113.19M | 6.39M | -117.26M | -79.08M | -12.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.46 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
739.04 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
683.93 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.34 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
281.94 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2026-02-17 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2026-01-29 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2026-01-29 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2026-01-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-28 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-28 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-11-13 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-08-14 | Eingeleitet | William Blair | Outperform |
| 2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
| 2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Eingeleitet | Cowen | Outperform |
| 2019-10-28 | Eingeleitet | Goldman | Buy |
| 2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Korro Bio raises $85 million in private equity financing By Investing.com - Investing.com Nigeria
Korro Bio Stock Gains After Tough 2025New Drug Candidate, Analyst Upgrades Boost Outlook - Sahm
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
RBC Capital Keeps Their Hold Rating on Korro Bio (KRRO) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB), Korro Bio (KRRO) and Pharming Group (PHAR) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Sagimet Biosciences, Inc. Class A (SGMT) and Bristol-Myers Squibb (BMY) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Oruka Therapeutics (ORKA) and Gilead Sciences (GILD) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Korro Bio (KRRO), Health Catalyst (HCAT) - The Globe and Mail
Korro Bio (KRRO) Losses Of US$117.3 Million Test Bullish Narratives On Profitability - simplywall.st
Korro Bio (KRRO) sellers register 7.65M common shares after $85M private placement - Stock Titan
Cantor Fitzgerald raises Korro Bio stock price target on UCD confidence - Investing.com Canada
Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot - Investing.com Nigeria
Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot By Investing.com - Investing.com UK
Insider Buying: New Enterprise Associates 17, L.P. Acquires Addi - GuruFocus
Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates - sharewise.com
Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Bitget
Korro Bio investor buys $2.3 million in KRRO stock By Investing.com - Investing.com
Advancing Genetic Medicines with RNA Editing: Inside the OPERA Platform and Therapeutic Strategies - Minichart
Korro Bio, Inc. (KRRO) reports Q4 loss, lags revenue estimates - MSN
Baskett Forest buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com
Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million By Investing.com - Investing.com South Africa
Korro Bio (KRRO) major holder adds stock and pre-funded warrants in March 2026 buy - Stock Titan
Insider fund tied to Carmen Chang boosts Korro Bio (KRRO) stake with 450,045 buys - Stock Titan
Korro 10-K: $6.4M Collaboration Revenue; $(12.48) EPS on $(117.3)M Net Loss - TradingView
Korro Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Korro Bio (NASDAQ: KRRO) expands RNA-editing pipeline as 2025 net loss deepens - Stock Titan
Korro Bio, Inc. (KRRO) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
Korro shares jump 17% following $85M private placement financing - MSN
Korro Bio (KRRO) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Korro Secures $85M Lifeline After Trial Setback - National Today
Korro Bio Raises $85 Million in Oversubscribed PIPE Financing to Advance RNA Editing Therapies and Extend Cash Runway into 2028 - Minichart
Korro Bio extends cash runway after trial fail, layoffs - The Business Journals
Korro Announces $85 Million Private Placement - citybiz
Korro Bio prices 4.5M shares at $11.11 in private placement - TipRanks
Korro Announces Oversubscribed $85 Million Private Placement - Bitget
Korro Bio Announces Oversubscribed $85M PIPE Financing - TipRanks
Korro stock surges 17% on $85M private placement financing By Investing.com - Investing.com India
Korro Bio raises $85 million in private equity financing - Investing.com
Korro Bio Raises $85 Million in Private Placement, Adds Investor Registration Rights - TradingView
Korro stock surges 17% on $85M private placement financing - Investing.com
Korro Bio (KRRO) secures $85M PIPE to extend cash runway into 2028 - Stock Titan
Investors pour $85M into RNA editor Korro Bio’s genetic disease drugs - Stock Titan
Korro Bio, Inc. $KRRO Stock Position Raised by JPMorgan Chase & Co. - MarketBeat
Bond Watch: Does Korro Bio Inc have pricing powerJuly 2025 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
Winners Losers: Should you avoid Korro Bio Inc stock right nowWeekly Earnings Recap & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Hold” from Analysts - Defense World
KRRO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
KRRO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Bond Watch: What is the next catalyst for Korro Bio IncTrade Volume Report & Precise Swing Trade Alerts - baoquankhu1.vn
Profit Recap: Will Korro Bio Inc benefit from green energy policiesQuarterly Market Summary & Breakout Confirmation Trade Signals - baoquankhu1.vn
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Korro Bio Inc-Aktie (KRRO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SANDELL SCOTT D | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| New Enterprise Associates 17, | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Chang Carmen | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| BASKETT FOREST | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Mathers Edward T | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Makhzoumi Mohamad | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Walker Paul Edward | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Florence Anthony A. Jr. | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
0.11%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):